Allarity Therapeutics Inc (ALLR)

Overview News Price History Financials Discussions Forecast Stock Split

Allarity Therapeutics Inc Stock (ALLR) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	-	-	-	-	-
Operating Expenses	13.10% 4.24	4.879	4.426	4.156	3.659
Interest Income/Expense	55.65% 0.102	0.23	0.034	0.142	0.092
Depreciation and Amortization	77.78% 0.002	0.009	0.009	0.009	0.01
Operating Income/Loss	13.10% -4.24	-4.879	-4.426	-4.156	-3.659
Nonoperating Income/Loss	0.393	-	-	-	-
Income/Loss From Continuing Operations Before Tax	134.72% -3.847	-1.639	-4.447	-2.38	-3.352
Income Tax Expense/Benefit, Deferred	-0.014	-	-	-	-
Income Tax Expense/Benefit	-0.004	-	-	-	-
Income/Loss From Continuing Operations After Tax	123.17% -3.843	-1.722	-4.447	-2.38	-3.352
Net Income/Loss	123.17% -3.843	-1.722	-4.447	-2.38	-3.352
Preferred Stock Dividends And Other Adjustments	0.037	-	1.105	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	82.92% 0.1753	1.0264	2.4747	0.3724	0.7581
Diluted Average Shares	82.92% 0.1753	1.0264	2.4747	0.3724	0.7581
Basic Earnings Per Share	342.76% -22.14	9.12	-2.24	-26.28	-4.43
Diluted Earnings Per Share	358.04% -22.14	8.58	-2.03	-26.28	-4.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	0.037	-	1.105	-	-

GMAB

$21.50

1.61%

INCY

$74.59

1.14%

UTHR

$370.49

2.02%

MRNA

$43.06

0.76%

BGNE

$215.00

4.29%

BNTX

$118.39

1.93%